Summit Global Investments’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,693
Closed -$255K 576
2024
Q1
$255K Sell
8,693
-1,200
-12% -$38.3K 0.02% 430
2023
Q4
$360K Buy
+9,893
New +$324K 0.02% 392
2022
Q1
Sell
-8,000
Closed -$385K 550
2021
Q4
$385K Sell
8,000
-600
-7% -$30.2K 0.02% 413
2021
Q3
$478K Sell
8,600
-1,600
-16% -$88.9K 0.04% 317
2021
Q2
$553K Buy
+10,200
New +$560K 0.03% 336

Other funds holding SRDX

Summit Global Investments's SRDX Position: Q2 2024 in Review

Summit Global Investments sold out of Surmodics (SRDX) in Q2 2024, closing a stake of 8,693 shares — an estimated $255K sold.

Summit Global Investments first reported a position in SRDX in Q2 2021 and held it in 5 quarters. The position peaked at $553K in Q2 2021. 124 funds tracked by Wall St. Rank hold SRDX as of Q2 2024.

  • Summit Global Investments reported no remaining Surmodics position as of Q2 2024 after selling out during the quarter.
  • Summit Global Investments sold 8,693 Surmodics shares in Q2 2024, an estimated $255K.
  • Summit Global Investments first reported a position in Surmodics in Q2 2021 and held it in 5 quarters.
  • Summit Global Investments's Surmodics position peaked at $553K in Q2 2021.
  • 124 funds tracked by Wall St. Rank held Surmodics as of Q2 2024.

Based on Summit Global Investments's 13F filing for Q2 2024, filed 22 Jul 2024.